697762-66-6 Usage
Description
1-((S)-1-tert-butyldiMethylsilyloxyMethyl-2-Methylpropyl)-6-(3-chloro-2-fluorobenzyl)-7-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ethyl ester is a complex ethyl ester derivative of a quinolone antibiotic, characterized by a fluoroquinolone core, a tert-butyldimethylsilyloxy group, and a chlorofluorobenzyl group. 1-((S)-1-tert-butyldiMethylsilyloxyMethyl-2-Methylpropyl)-6-(3-chloro-2-fluorobenzyl)-7-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ethyl ester is likely to possess antibacterial properties due to its structural similarity to other quinolone antibiotics, with its specific chemical modifications potentially influencing its pharmacokinetics and potency. It holds promise for pharmaceutical research and the development of novel antibiotics.
Uses
Used in Pharmaceutical Research:
1-((S)-1-tert-butyldiMethylsilyloxyMethyl-2-Methylpropyl)-6-(3-chloro-2-fluorobenzyl)-7-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ethyl ester is used as a research compound for the development of new antibiotics. Its unique molecular structure and potential antibacterial properties make it a valuable candidate for further investigation and optimization in the fight against bacterial infections.
Used in Antibacterial Applications:
In the medical industry, 1-((S)-1-tert-butyldiMethylsilyloxyMethyl-2-Methylpropyl)-6-(3-chloro-2-fluorobenzyl)-7-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ethyl ester is used as an antibacterial agent. Its structural resemblance to quinolone antibiotics suggests that it may be effective in treating bacterial infections, particularly those resistant to conventional antibiotics. The specific chemical modifications in its structure could enhance its potency and selectivity, making it a promising option for the development of new therapeutics.
Used in Drug Development:
1-((S)-1-tert-butyldiMethylsilyloxyMethyl-2-Methylpropyl)-6-(3-chloro-2-fluorobenzyl)-7-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ethyl ester is utilized in the development of new drugs, particularly within the pharmaceutical industry. Its potential antibacterial properties and unique molecular structure make it an attractive candidate for the creation of novel therapeutics to address the growing need for new antibiotics in the face of increasing antibiotic resistance.
Check Digit Verification of cas no
The CAS Registry Mumber 697762-66-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,7,7,6 and 2 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 697762-66:
(8*6)+(7*9)+(6*7)+(5*7)+(4*6)+(3*2)+(2*6)+(1*6)=236
236 % 10 = 6
So 697762-66-6 is a valid CAS Registry Number.
697762-66-6Relevant articles and documents
AN IMPROVED PROCESS FOR THE PREPARATION OF ELVITEGRAVIR
-
Page/Page column 29, (2011/02/24)
The present invention relates to improved process for the preparation of elvitegravir (12), wherein the compound of formula (6) is protected with suitable protecting agents and further reacted with formula (9) in the presence of tetrakis(triphenylphosphin
Novel HIV-1 integrase inhibitors derived from quinolone antibiotics
Sato, Motohide,Motomura, Takahisa,Aramaki, Hisateru,Matsuda, Takashi,Yamashita, Masaki,Ito, Yoshiharu,Kawakami, Hiroshi,Matsuzaki, Yuji,Watanabe, Wataru,Yamataka, Kazunobu,Ikeda, Satoru,Kodama, Eiichi,Matsuoka, Masao,Shinkai, Hisashi
, p. 1506 - 1508 (2007/10/03)
The viral enzyme integrase is essential for the replication of human immunodeficiency virus type 1 (HIV-1) and represents a remaining target for antiretroviral drugs. Here, we describe the modification of a quinolone antibiotic to produce the novel integr
